Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2003
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/29/2003US20030100490 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
05/29/2003US20030100486 Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
05/29/2003US20030100484 Cell in which a urotensin II receptor is formed is contacted with a chemical compound; activity or quantity of a gene, or its gene product, from the cell from is determined, comparing with gene product of control cell
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099725 For therapy and prophylaxis of cancers especially cancer of lung, esophagus, stomach, oral cavity and prostate as well as for therapy of Helicobacter pylori infection; useful as adjuncts to conventional surgery or radiotherapy
05/29/2003US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity
05/29/2003US20030099712 Therapeutic coating for an intravascular implant
05/29/2003US20030099705 Sustained release ranolazine formulations
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1314728A1 Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives
05/28/2003EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314425A1 Medicinal compositions for preventing or treating heart failure
05/28/2003EP1314424A1 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
05/28/2003EP1314423A1 Medicinal compositions
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1313874A1 Pharmaceutical compositions comprising a modulator of adamts-1
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313844A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313766A2 Coaster, a human coactivator of steroid receptors
05/28/2003EP1313737A1 Novel guanidino derivatives as inhibitors of cell adhesion
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313730A1 Pyrrolidine derivatives and their use as chymase inhibitor
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313717A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313715A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313706A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
05/28/2003EP1313574A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313499A1 Method for treating the central nervous system by administration of igf structural analogs
05/28/2003EP1313490A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
05/28/2003EP1313488A1 Compositions and methods for improving cardiovascular function
05/28/2003EP1313481A1 Pharmaceutical composition comprising condensed indole compound
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1150664B1 Novel use of orexin receptor antagonists
05/28/2003EP1146865B1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
05/28/2003EP1143945B1 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
05/28/2003EP1140188B1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0904097B1 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420891A Pharmaceutical compound
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420862A Method for synthesis of N-ÒÇö(S)-1-carboxybutylÒÇò-(S)- alanine esters and use in synthesis of perindopril
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420788A Improved treatment of neovascularization
05/28/2003CN1420776A Inhibition of cyclooxygenase-2 activity
05/28/2003CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/28/2003CN1420771A Hydrophilic molecular disperse solutions of carvedilol
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420766A Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
05/28/2003CN1420114A 2,3-disubstd. -4(3H)-quinazolones
05/28/2003CN1419934A Medicinal composition for treating brain apoplexy
05/28/2003CN1109681C Flavone chromium, its producing method and use thereof
05/28/2003CN1109675C Arylpyrimidine derivs.
05/28/2003CN1109549C Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process
05/28/2003CN1109547C Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine deriv. and HMG-CoA reductase inhibitor
05/27/2003US6570037 Reacting a primary amine derivative containing another secondary or tertiary amine with a nitrobenzene containing carbonyl halide group
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
1 ... 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 ... 1595